Valuation : DarioHealth Corp.

Market Cap 66.34M 57.17M 53.6M 48.93M 92.17M 6.34B 92.47M 636M 248M 3.2B 249M 244M 10.61B P/E 2026 *
-1.78x
P/E 2027 * -3.01x
Enterprise Value 66.34M 57.17M 53.6M 48.93M 92.17M 6.34B 92.47M 636M 248M 3.2B 249M 244M 10.61B EV / Sales 2026 *
3.06x
EV / Sales 2027 * 2.11x
Free-Float
84.12%
Yield 2026 *
-
Yield 2027 * -
1 week-9.61%
Current month-6.88%
1 month-9.67%
3 months-9.97%
6 months-43.44%
Current year-40.51%
1 week 6.45
Extreme 6.45
7.72
1 month 6.19
Extreme 6.19
8.2
Current year 5.84
Extreme 5.8445
13.64
1 year 5.84
Extreme 5.8445
17.74
3 years 5.84
Extreme 5.8445
69.8
5 years 5.84
Extreme 5.8445
387.8
10 years 5.84
Extreme 5.8445
1,880
Manager TitleAgeSince
Corporate Officer/Principal - 11/08/2011
Chief Executive Officer 52 09/08/2013
Director of Finance/CFO 38 01/01/2021
Director TitleAgeSince
Chairman 52 23/11/2014
Director/Board Member 68 12/11/2013
Director/Board Member 57 23/11/2014
Date Insider Type Main position Quantity % Market Cap.
23/07/26 Buy

Director

14,430 0.1973%
10/04/26 Other

Director

4,500 0.0616%
11/09/25 Free

Director

20,000 0.0440%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-9.61%-33.50%-88.72% 66.34M
+0.79%-3.58%-14.39%+9.42% 195B
+1.40%-2.27%-0.79%+12.09% 117B
+0.25%+1.25%+11.09%+78.52% 61.45B
-0.25%-1.97%+26.78%+53.11% 51.03B
+0.74%-1.29%-0.90%-32.69% 51.62B
+1.71%-1.65%+20.96%-8.53% 34.27B
+1.82%+2.98% - - 30.95B
-2.49%-4.42%+37.49%-16.34% 23.75B
-0.82%-1.17%-4.66%+18.23% 23.41B
Average +0.32%-1.95%+4.68%+2.79% 58.79B
Weighted average by Cap. +0.67%-1.86%+1.09%+15.86%

Financials

2026 *2027 *
Net sales 21.71M 18.71M 17.54M 16.01M 30.16M 2.07B 30.26M 208M 81.2M 1.05B 81.51M 79.74M 3.47B 31.47M 27.12M 25.42M 23.21M 43.72M 3.01B 43.86M 302M 118M 1.52B 118M 116M 5.03B
Net income -32.62M -28.11M -26.36M -24.06M -45.32M -3.12B -45.47M -313M -122M -1.57B -122M -120M -5.22B -21.4M -18.44M -17.29M -15.78M -29.73M -2.04B -29.82M -205M -80.02M -1.03B -80.33M -78.58M -3.42B
Net Debt - -
Logo DarioHealth Corp.
DarioHealth Corp. is a global digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by data analytics, software, and personalized coaching. The Company’s platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. Its digital therapeutic platform has been designed with a user-first strategy, focusing on the user’s needs and user experience and satisfaction. Dario Blood Glucose Monitoring Starter Kit is a pocket-sized smartphone glucometer that manages diabetes in one ultra-compact device. Dario Blood Pressure Monitoring System is a blood pressure monitoring system used to measure blood pressure, which allows it to store all its user readings in the Dario App. The Dario mobile app is a complete, cloud-based solution for personal chronic condition management.
Employees
163
Date Price Change Volume
28/08/26 $6.770 0.00% 17,904
27/08/26 $6.770 -3.70% 21,111
26/08/26 $7.030 -4.87% 34,026
25/08/26 $7.390 +2.50% 123,548
24/08/26 $7.210 -3.74% 10,313
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
6.770USD
Average target price
14.00USD
Spread / Average Target
+106.79%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. DRIO Stock